Cipla Limited — Important, 04-07-2026: Updates
04-07-2026 | 06:58 pm
04-07-2026 | 06:58 pm
Cipla achieved record revenue exceeding ₹28,000 Cr, with India business topping ₹12,500 Cr. Cash reserves are strong at ₹11,000 Cr. The company is advancing complex generics, biosimilars, and new product launches, including generic Ventolin. The Goa facility cleared inspection. A ₹13/share dividend was declared.
No comments yet. Be the first to comment!
